Abstract
Coumarin components from Psoralea corylifolia L. are novel drugs in which psoralen and isopsoralen are the active components. The pharmacokinetics, tissue distribution and excretion of the two compounds were studied by liquid chromatography-tandem mass spectrometry after intravenous administration to Wistar rats. The elimination half-lives of psoralen and isopsoralen were 4.88 and 5.35 h. After dosing, the area under the curves of the tissues decreased in the following order: liver > lung > heart > kidney > spleen > brain for psoralen; and kidney > lung > liver > heart > spleen > brain for isopsoralen. After dosing, 51.27% of psoralen and 56.25% of isopsoralen were excreted as prototype, and urine was the major excretion route. In addition, the pharmacokinetics of psoralen and isopsoralen after oral administration to Wistar rats were also studied. The elimination half-lives of psoralen and isopsoralen were 4.13 and 5.56 h, and their relative bioavailabilities were 61.45% and 70.35%. Overall, the results show that coumarin components from P. corylifolia L. have high oral bioavailability, they are rapidly and widely distributed into tissues after intravenous administration, but they are slowly cleared and excreted.
Similar content being viewed by others
References
Jia, L. and Zhao, M. R., Applied studies on trace element in looking for new active substance. Acta. Bot. Boreal.-Occident. Sin., 21, 579–583 (2001).
Ahn, B. Z., Inhibitory effect of radix saponions on adhesion of some Solid tumor cells and relation to hemolytic action screening of 232 herbal drugs from anti-cell adhesion. Planta Med., 64, 220–224 (1998).
Luo, Z. D. and Guo, Y. H., Optimal extraction of Psoralea corylifolia L. Acta. Pharmacol. Sin., 16, 705–708 (1998).
Guo, L. Q. and Yamazoe, Y., Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herb al medicines. Acta. Pharmacol. Sin., 2, 129–136 (2004).
Ciaravino, V., Pharmacokinetic and toxicology assessment of intercept (S-59 and UVA treated) platelets. Hum. Exp. Toxicol., 20, 533–550 (2001).
Tsai, W. J. and Hsin, W. C., Antiplatelet flavorioids from seeds of Psoralea corylifolia L. J. Nat. Prod., 59, 671–672 (2006).
Stolk, L. M. and Siddiqui, A. H., Biopharmaceutics, pharmacokinetics and pharmacology of psoralen. Gen. Pharmacol., 19, 649–653 (1988).
Huang, X., Jiang, Y. P., and Wang, Y. P., Fit of compartment model of psoralen and bioavailability. J. Fourth. Mil. Med. Univ., 5, 349–351 (1991).
Huang, X. and Yang Y. C., Detection of psoralcn by reversedphase HPLC in whole blood. J. Fourth. Mil. Med. Univ., 3, 210–213 (1991).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Feng, L., Wang, L. & Jiang, X. Pharmacokinetics, tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats. Arch. Pharm. Res. 33, 225–230 (2010). https://doi.org/10.1007/s12272-010-0206-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0206-5